{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T05:04:33Z","timestamp":1750309473280,"version":"3.41.0"},"publisher-location":"New York, NY, USA","reference-count":17,"publisher":"ACM","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.acm.org\/publications\/policies\/copyright_policy#Background"}],"content-domain":{"domain":["dl.acm.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,13]]},"DOI":"10.1145\/3706890.3707014","type":"proceedings-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T13:37:20Z","timestamp":1736775440000},"page":"726-730","update-policy":"https:\/\/doi.org\/10.1145\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["ApoE Genetic Testing and Personalized Nutrition Service"],"prefix":"10.1145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1387-5909","authenticated-orcid":false,"given":"Jitao","family":"Yang","sequence":"first","affiliation":[{"name":"School of Information Science, Beijing Language and Culture University, Beijing, China"}]}],"member":"320","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"key":"e_1_3_3_1_1_2","doi-asserted-by":"crossref","unstructured":"Yin Y Wang Z. 2018. ApoE and Neurodegenerative Diseases in Aging. Adv Exp Med Biol. 2018;1086:77-92.","DOI":"10.1007\/978-981-13-1117-8_5"},{"key":"e_1_3_3_1_2_2","doi-asserted-by":"crossref","unstructured":"Jia L Du Y Chu L et al. 2020. Prevalence risk factors and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health. 2020 Dec;5(12):e661-e671.","DOI":"10.1016\/S2468-2667(20)30185-7"},{"key":"e_1_3_3_1_3_2","first-page":"501","volume":"2019","author":"Yamazaki Y","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G. 2019. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019 Sep;15(9):501-518.","journal-title":"Nat Rev Neurol."},{"key":"e_1_3_3_1_4_2","volume":"2000","author":"Sheehan D","unstructured":"Sheehan D, Bennett T, Cashman K. 2000. Apolipoprotein E gene polymorphisms and serum cholesterol in healthy Irish adults: a proposed genetic marker for coronary artery disease risk. Ir J Med Sci. 2000 Jan-Mar;169(1):50-4.","journal-title":"Ir J Med Sci."},{"key":"e_1_3_3_1_5_2","doi-asserted-by":"crossref","unstructured":"Sattar N Gaw A Scherbakova O et al. 2003. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003 Jul 29;108(4):414-9.","DOI":"10.1161\/01.CIR.0000080897.52664.94"},{"key":"e_1_3_3_1_6_2","unstructured":"Yang Z Zhu T Ma G et al. 2001. Apolipoprotein E polymorphism in the early onset of coronary heart disease. Chin Med J (Engl). 2001 Sep;114(9):983-5."},{"key":"e_1_3_3_1_7_2","first-page":"368","volume":"2003","author":"Wang CH","unstructured":"Wang CH, Zhou X. 2003. Meta-analysis for relationship between apoE gene polymorphism and coronary heart disease. Chinese Journal of Preventive Medicine. 2003 Sep;37(5):368-70. Chinese.","journal-title":"Preventive Medicine."},{"key":"e_1_3_3_1_8_2","doi-asserted-by":"crossref","unstructured":"Fritsche LG Freitag-Wolf S Bettecken T et al. 2009. Age-related macular degeneration and functional promoter and coding variants of the apolipoprotein E gene. Hum Mutat. 2009 Jul;30(7):1048-53.","DOI":"10.1002\/humu.20957"},{"key":"e_1_3_3_1_9_2","doi-asserted-by":"crossref","unstructured":"Bennet AM Di Angelantonio E Ye Z et al. 2007. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA. 2007 Sep 19;298(11):1300-11.","DOI":"10.1001\/jama.298.11.1300"},{"key":"e_1_3_3_1_10_2","doi-asserted-by":"crossref","unstructured":"Shahid SU S Cooper JA Beaney KE Li K Rehman A Humphries SE. 2016. Effect of SORT1 APOB and APOE polymorphisms on LDL-C and coronary heart disease in Pakistani subjects and their comparison with Northwick Park Heart Study II. Lipids Health Dis. 2016 Apr 26;15:83.","DOI":"10.1186\/s12944-016-0253-0"},{"key":"e_1_3_3_1_11_2","doi-asserted-by":"crossref","unstructured":"Curti ML Jacob P Borges MC Rogero MM Ferreira SR. 2011. Studies of gene variants related to inflammation oxidative stress dyslipidemia and obesity: implications for a nutrigenetic approach. J Obes. 2011;2011:497401.","DOI":"10.1155\/2011\/497401"},{"key":"e_1_3_3_1_12_2","first-page":"94","volume":"2022","author":"Xi N","unstructured":"Xi N, Wang Y, Zhou J, Li Y, Ruan S. 2022. Influence of ApoE gene polymorphisms on therapeutic effects of lipid-lowering statins among patients with ischemic cerebral infarction. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2022 Jan 10;39(1):94-98. Chinese.","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi."},{"key":"e_1_3_3_1_13_2","doi-asserted-by":"crossref","unstructured":"Tomaszewski N He X Solomon V et al. 2020. Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA) Eicosapentaenoic Acid Arachidonic Acid and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial. J Alzheimers Dis. 2020;74(3):975-990.","DOI":"10.3233\/JAD-191017"},{"key":"e_1_3_3_1_14_2","volume-title":"Carriers: A Review. JAMA Neurol. 2017 Mar 1;74(3):339-347.","author":"Yassine HN","year":"2017","unstructured":"Yassine HN, Braskie MN, Mack WJ, et al. 2017. Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E \u03b54 Carriers: A Review. JAMA Neurol. 2017 Mar 1;74(3):339-347."},{"key":"e_1_3_3_1_15_2","doi-asserted-by":"crossref","unstructured":"Masson LF McNeill G Avenell A. 2003. Genetic variation and the lipid response to dietary intervention: a systematic review. Am J Clin Nutr. 2003 May;77(5):1098-111.","DOI":"10.1093\/ajcn\/77.5.1098"},{"key":"e_1_3_3_1_16_2","doi-asserted-by":"crossref","unstructured":"Schaefer EJ Lamon-Fava S Ausman LM et al. 1997. Individual variability in lipoprotein cholesterol response to National Cholesterol Education Program Step 2 diets. Am J Clin Nutr. 1997 Mar;65(3):823-30.","DOI":"10.1093\/ajcn\/65.3.823"},{"key":"e_1_3_3_1_17_2","doi-asserted-by":"crossref","unstructured":"Norwitz NG Saif N Ariza IE Isaacson RS. 2021. Precision Nutrition for Alzheimer's Prevention in ApoE4 Carriers. Nutrients. 2021 Apr 19;13(4):1362.","DOI":"10.3390\/nu13041362"}],"event":{"name":"ISAIMS 2024: 2024 5th International Symposium on Artificial Intelligence for Medicine Science","acronym":"ISAIMS 2024","location":"Amsterdam Netherlands"},"container-title":["Proceedings of the 2024 5th International Symposium on Artificial Intelligence for Medicine Science"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3706890.3707014","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/3706890.3707014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T01:17:20Z","timestamp":1750295840000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3706890.3707014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":17,"alternative-id":["10.1145\/3706890.3707014","10.1145\/3706890"],"URL":"https:\/\/doi.org\/10.1145\/3706890.3707014","relation":{},"subject":[],"published":{"date-parts":[[2024,8,13]]},"assertion":[{"value":"2025-01-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}